Les nanobodies, nouvelle génération de médicament ... - DUMAS
CrossMab technology for the development of therapeutic bispecific antibodies and. 438 antibody fusion proteins, MAbs 13(1) (2021) 1967714 ...
A nanobody-enzyme fusion protein targeting PD-L1 and sialic acid ...Gruijl TD, van der Vliet HJ. Highly specific and potently activating. Vg9Vd2-T cell specific nanobodies for diagnostic and therapeutic. A bispecific nanobody approach to leverage the potent and widely ...Gruijl TD, van der Vliet HJ. Highly specific and potently activating. Vg9Vd2-T cell specific nanobodies for diagnostic and therapeutic. La Propriété Industrielle - WIPObedingt und Stand der Technik. Ausfälle von elektroni- schen Betriebsgeräten und LED-Modulen, die innerhalb der Nennausfallrate von 0 ...
Autres Cours:
